Packages

• Total Complement CH50/CH100 Assay

  A screening test for the activation of the classical complement pathway is total complement activity/CH 50, sometimes referred to as CH 100. It is susceptible to any route component being reduced, removed, or rendered inactive. In order to more accurately ascertain the occurrence, severity, and response to treatment, the total complement activity test can thoroughly comprehend the complement system's activation status. The most popular techniques for determining the complement system's functional activity are automated techniques such liposome lysis and enzyme-linked immunosorbent assay (ELISA) or hemolysis assays. With the help of Creative Biolabs' comprehensive complement function assay platform, it is possible to identify each of the three pathways' individual activities independently of one another.

  Gemini Smith 19 Sep 2024 Version 9.0 Views Downloads 23 Nov 2024

• Neural Gene Expression Vectors

  With our ready-to-use expression vectors, you can skip the time-consuming cloning, validation, and sequence analysis steps. We provide an array of expression systems, promoter clones, fusion tags and screening markers, and you can customize or purchase pre-made, ready-to-use neural gene expression vectors.

  Gemini Smith 13 Aug 2024 Version 7.0 Views Downloads 23 Nov 2024

• Baby Rabbit Complement Serum

  Baby Rabbit Complement Serum is a Complement Serum freshly prepared from Rabbit whole blood in cold and then frozen at -80°C to prevent degradation of complement activity. It can be used in the hemolytic plaque assays, complement fixation assays, and other lymphocytotoxicity and hemolytic procedures. This product is for research use only and is not intended for therapeutic or diagnostic applications.

  Gemini Smith 13 Aug 2024 Version 9.0 Views Downloads 23 Nov 2024

• Esophageal Cancer Biomarker

  Creative Biolabs is a leading CRO company specialized in antibody development. Based on our powerful technology platforms, we offer high-quality in vitro diagnostic (IVD) antibody development services targeting a wide range of biomarkers of different diseases. Here, we focus on esophageal cancer. Check our esophageal cancer biomarker

  Gemini Smith 13 Aug 2024 Version 8.0 Views Downloads 23 Nov 2024